menu
    • menu

    Company profile for Bioniz Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bioniz Therapeutics is an emerging biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and cancer. Originating in research conducted at the National Institutes of Health (NIH), Bioniz is leveraging its expertise in cytokine biology to create a new class of therapeutics that ...
    Bioniz Therapeutics is an emerging biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and cancer. Originating in research conducted at the National Institutes of Health (NIH), Bioniz is leveraging its expertise in cytokine biology to create a new class of therapeutics that will tackle the issue of cytokine redundancy. Cytokine redundancy refers to how the immune system uses multiple cytokines sharing overlapping functions to prevent immune system failures from single cytokine malfunctions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bioniz TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5 Mason St, Suite 275. Irvine, CA 92618
    Telephone
    Telephone
    +1 949 273-6000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bioniz.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Equillium triples clinical pipeline with $329M Bioniz takeover
    Equillium triples clinical pipeline with $329M Bioniz takeover

    17 Feb 2022

    // PHARMAPHORUM

    https://pharmaphorum.com/news/equillium-triples-clinical-pipeline-with-329m-bioniz-takeover/

    PHARMAPHORUM
    17 Feb 2022
    Share Share
    Bioniz Therapeutics Receives Orphan Drug Designation from the European BNZ-1
    Bioniz Therapeutics Receives Orphan Drug Designation from the European BNZ-1

    06 Apr 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bioniz-therapeutics-receives-orphan-drug-designation-from-the-european-commission-for-bnz-1-for-treatment-of-cutaneous-t-cell-lymphoma-301261441.html

    PRNEWSWIRE
    06 Apr 2021
    Share Share
    Bioniz Therapeutics Appoints Dr. Alexandre Kaoukhov to Leadership Team
    Bioniz Therapeutics Appoints Dr. Alexandre Kaoukhov to Leadership Team

    24 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bioniz-therapeutics-appoints-dr-alexandre-kaoukhov-to-leadership-team-301254463.html

    PRNEWSWIRE
    24 Mar 2021
    Share Share
    Bioniz announces positive efficacy safety data for BNZ-1 from interim analysis
    Bioniz announces positive efficacy safety data for BNZ-1 from interim analysis

    20 Jul 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bioniz-announces-positive-efficacy-and-safety-data-for-bnz-1-from-interim-analysis-of-phase-12-study-in-cutaneous-t-cell-lymphoma-301095609.html

    PRNEWSWIRE
    20 Jul 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search